ChemDiv chemistry of cures

ChemDiv, Inc. signs research and collaboration agreement with Janssen Pharmaceutica NV and Tibotec Pharmaceuticals for integrated drug discovery projects

ChemDiv Research Institute (CDRI) at the ChemRar Hi-Tech Centre announced that it has signed collaboration and license option agreement with the Singapore based Novartis Institute for Tropical Diseases (NITD) to undertake discovery and development of patentable chemical compounds to find new, faster cures for Tuberculosis.

San Diego, California, August 20th, 2011 - ChemDiv,Inc (www.chemdiv.com), global provider of the world’s largest collection of commercially available small-molecule compounds, announced today that it has entered into an Exclusive Distribution Agreement with Shanghai Topscience Co., Ltd, (www.tsbiochem.com), a China based company focused on sales and marketing of chemical libraries for drug discovery needs.

Pfizer And Chemrar High Tech Center Announce Plans To Explore  
Innovative Medical Research And Development Partnership In Russia

Collaboration Focused on Addressing Unmet Medical Needs of Patients in Cancer, Cardiovascular, Central Nervous System, and Other Major Therapeutic Areas that Impact the Russian Population

Denis Manturov, Deputy Minister of Industry and Trade of the Russian Federation, Participated at BIO International Convention 2011 in Washington, DC

The delegation of Ministry of Industry and Trade of the Russian Federation headed by Denis Valentinovich Manturov took part in the largest international biotechnology Convention (BIO 2011)

PRESS RELEASE

Viriom successfully completes clinical safety trial with novel NNRTI, advances to efficacy studies in HIV-infected patients, and to development of HIV microbicide formulation

ChemRar High-Tech Center has entered into an Initial Non-Binding Agreement on Collaboration with Janssen Pharmaceutica NV. The document outlines  that the parties intend to work to identify and explore joint research projects with the intention to contribute to the innovative development of the Russian pharmaceutical industry.

Emerald BioStructures and ChemDiv Establish Co-Marketing Collaboration

-Complementary services address market demand for integrated structure-based drug discovery-

San Diego, CA – ChemDiv, Inc., global provider of the world’s largest collection of commercially available small-molecule compounds, announces the release of the unique E-Commerce portal at http://eshop.chemistryondemand.com. Supported by MolSoft, LLC., breakthrough mechanisms in molecular graphics and visualization, the web-based instrument integrates the cutting-edge chemical knowledge and technological know-how into the powerful platform, which allows instant and easy search and online ordering.

Prime Minister Outlines Initiative to Further Develop the Pharmaceutical Industry by 2020

The Russian government took a major step towards developing its pharmaceutical industry with an announcement made during a recent meeting at ChemRar Hi-Tech Center, a ChemDiv’s Research Facility located in Moscow, Russia. The meeting held with Prime Minister Vladimir Putin, Moscow Regional Governor Boris Gromov, the Minister of Health and Social Development Tatyana Golikova, the Minister of Industry and Trade Viktor Khristenko and company officials outlined the future development of the industry by the year 2020.